» Authors » Francis D Mwansa

Francis D Mwansa

Explore the profile of Francis D Mwansa including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 112
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Carcelen A, Prosperi C, Hamahuwa M, Kapungu K, Chongwe G, Mwansa F, et al.
PLOS Glob Public Health . 2024 Jun; 4(6):e0002985. PMID: 38941295
Nested serosurveys within routine service delivery platforms such as planned supplemental immunization activities (SIAs) provide an opportunity to collect information that can be used to answer valuable questions on the...
2.
Winter A, Takahashi S, Carcelen A, Hayford K, Mutale W, Mwansa F, et al.
PLOS Glob Public Health . 2023 May; 3(5):e0000554. PMID: 37130089
Implications of the COVID-19 pandemic for both populations and healthcare systems are vast. In addition to morbidity and mortality from COVID-19, the pandemic also disrupted local health systems, including reductions...
3.
Carcelen A, Winter A, Moss W, Chilumba I, Mutale I, Chongwe G, et al.
Sci Rep . 2022 Jun; 12(1):10217. PMID: 35715547
High-quality, representative serological surveys allow direct estimates of immunity profiles to inform vaccination strategies but can be costly and logistically challenging. Leveraging residual serum samples is one way to increase...
4.
Carcelen A, Prosperi C, Mutembo S, Chongwe G, Mwansa F, Ndubani P, et al.
Hum Vaccin Immunother . 2021 Jul; 18(1):1-6. PMID: 34227914
With unprecedented speed, multiple vaccines against SARS-CoV-2 are available 1 year after the COVID-19 pandemic was first identified. As we push to achieve global control through these new vaccines, old...
5.
Carcelen A, Mutembo S, Matakala K, Chilumba I, Mulundu G, Monze M, et al.
Am J Trop Med Hyg . 2021 May; 104(6):2229-2232. PMID: 33939639
Zambia conducted a measles and rubella (MR) vaccination campaign targeting children 9 months to younger than 15 years of age in 2016. This campaign was the first introduction of a...
6.
Carcelen A, Hayford K, Moss W, Book C, Thuma P, Mwansa F, et al.
PLoS One . 2020 Oct; 15(10):e0240734. PMID: 33057405
Background: Serosurveys are a valuable surveillance tool because they provide a more direct measure of population immunity to infectious diseases, such as measles and rubella, than vaccination coverage estimates. However,...
7.
Feldhaus I, Schutte C, Mwansa F, Undi M, Banda S, Suharlim C, et al.
Health Policy Plan . 2019 Jun; 34(5):327-336. PMID: 31157376
Donors, researchers and international agencies have made significant investments in collection of high-quality data on immunization costs, aiming to improve the efficiency and sustainability of services. However, improved quality and...
8.
Hayford K, Mutembo S, Carcelen A, Matakala H, Munachoonga P, Winter A, et al.
Vaccine . 2019 Mar; 37(17):2387-2393. PMID: 30905529
Background: Serological surveys can potentially complement vaccine coverage surveys, such as post-vaccination campaign coverage evaluation surveys (PCES), by providing direct information on population immunity within and outside the target age...
9.
Mutembo S, Carcelen A, Mwansa F, Searle K, Wanyiri J, Book C, et al.
Am J Trop Med Hyg . 2018 Oct; 99(6):1639-1642. PMID: 30277204
Age-specific population immunity to many vaccine-preventable diseases can be measured using serological surveys. However, stand-alone serological surveys are infrequently conducted in low- and middle-income countries because of costs, operational challenges,...